Research Article
Assessing the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Stage I Non-Small-Cell Lung Cancer with Complete Resection
Table 1
Baseline characters of the 190 patients.
| | Variable | N (%) |
| | Gender |
| | Male | 98 (51.6) | | Female | 92 (48.4) |
| | Age at diagnosis(years) | | ≥65 | 69 (36.3) | | <65 | 121 (63.7) |
| | Smoking history | | Smoker | 70 (37) | | Nonsmoker | 119 (63) |
| | Surgical resection | | Sublobar resection | 8 (4.2) | | Lobectomy | 181 (95.8) |
| | Histologic type | | Adenocarcinoma | 146 (76.8) | | Lepidic-predominant | 20 (10.5) | | Acinar-predominant | 30 (15.8) | | Papillary-predominant | 73 (38.4) | | Micropapillary-predominant | 3 (1.6) | | Solid-predominant | 12 (6.3) | | Adenocarcinogenesis | 8 (4.2) | | Squamous | 26 (13.7) | | Others | 18 (9.5) |
| | Stage | | IA1 | 15 (7.9) | | IA2 | 80 (42.1) | | IA3 | 45 (23.7) | | IB | 50 (26.3) |
| | Differentiation | | Poor | 51 (26.8) | | Moderate | 38 (20.0) | | Well | 97 (51.1) | | Unknown | 4 (2.1) |
| | Chemotherapy | | Yes | 109 (57.4) | | No | 81(42.6) |
| | Tumor location | | Upper lobe | 118 (62.1) | | Middle lobe | 21 (11.1) |
| | Visceral pleural invasion | | Absent | 164 (86.3) | | Present | 26 (13.7) |
| | Lymphovascular invasion | | Absent | 151 (79.5) | | Present | 37 (20.5) |
| | Recurrence | | Yes | 68 (35.8) | | No | 122 (64.2) |
| | Survival | | Yes | 154 (81.1) | | No | 24 (12.6) | | Unknown | 12 (6.3) |
| | CEA (ng/ml) | | ≥5 | 37 (19.5) | | <5 | 143 (75.3) |
| | CYFRA211 (ng/ml) | | ≥3.3 | 43 (22.6) | | <3.3 | 138 (72.6) |
| | NLR | | ≥2.84 | 36 (18.9) | | <2.84 | 153 (80.5) |
| | RDW-SD (fl) | | ≥43.65 | 54 (28.4) | | <43.65 | 135 (71.1) |
| | LDH (u/l) | | ≥191.5 | 55 (28.9) | | <191.5 | 135 (71.1) |
|
|
